ARAY logo

Accuray Incorporated (ARAY) Stock

Profile

Sector:

Healthcare

Country:

United States

IPO:

08 February 2007

Indexes:

Not included

Description:

Accuray Incorporated is a medical technology company that specializes in developing advanced radiation therapy systems for cancer treatment. Their innovative products, like the CyberKnife and TomoTherapy systems, aim to deliver precise and effective radiation while minimizing damage to surrounding healthy tissue, improving patient outcomes in cancer care.

Key Details

Price

$2.08

Annual Revenue

$446.55 M(-0.24% YoY)

Annual EPS

-$0.16(-60.00% YoY)

Annual ROE

-31.49%

Beta

2.35

Events Calendar

Earnings

Next earnings date:

Jan 31, 2025

Recent quarterly earnings:

Nov 06, 2024

Recent annual earnings:

Aug 14, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

N/A

Analyst ratings

Recent major analysts updates

13 Feb '24 Roth MKM
Buy
04 Oct '23 B. Riley Securities
Buy
31 Aug '22 B. Riley Securities
Buy
24 June '22 BTIG
Buy
23 June '22 B. Riley Securities
Buy
22 Dec '21 Loop Capital
Buy
21 Jan '20 BTIG Research
Buy
21 Jan '20 BTIG
Buy
01 Nov '18 Citigroup
Neutral
17 Aug '18 Citigroup
Sell

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Efficiency

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Institutional Ownership

Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)
Here Is Why Bargain Hunters Would Love Fast-paced Mover Accuray (ARAY)
ARAY
zacks.com03 January 2025

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

5 Beaten-Down MedTech Stocks Set to Rebound in 2025
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
5 Beaten-Down MedTech Stocks Set to Rebound in 2025
ARAY
zacks.com30 December 2024

Investors may want to take a closer look at discounted stocks, such as MCK, HAE, ARAY, LIVN and PBH, in the present market landscape.

New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
New Data Indicates the CyberKnife® System Can Provide a Safe and Effective Treatment Option to Control Brainstem Metastases, an Extremely Challenging Location to Treat
ARAY
prnewswire.com18 December 2024

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications MADISON, Wis., Dec. 18, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today an international retrospective multicenter analysis found that radiosurgery (SRS) and fractionated stereotactic radiotherapy (FSRT), delivered with the CyberKnife® System, can provide an effective and time-saving treatment option for brainstem metastases (BSM).

Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY)
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY)
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Accuray (ARAY)
ARAY
zacks.com16 December 2024

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Accuray (ARAY) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Here's Why You Should Add Accuray Stock in Your Portfolio Now
Here's Why You Should Add Accuray Stock in Your Portfolio Now
Here's Why You Should Add Accuray Stock in Your Portfolio Now
ARAY
zacks.com10 December 2024

ARAY's solid product demand and revenue growth raise optimism about the stock.

Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks
Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks
Accuray Q1 Earnings Meet Estimates, Sales Beat, Gross Margin Shrinks
ARAY
zacks.com07 November 2024

ARAY's first-quarter fiscal 2025 earnings meet estimates. Both the top and bottom lines deteriorate year over year.

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript
ARAY
seekingalpha.com06 November 2024

Accuray Incorporated (ARAY) Q1 2025 Earnings Call Transcript

Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
Accuray to Report First Quarter Fiscal 2025 Financial Results on November 6, 2024
ARAY
prnewswire.com23 October 2024

MADISON, Wis., Oct. 23, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the first quarter of fiscal year 2025, ended September 30, 2024, during a conference call hosted by company management at 1:30 p.m.

Accuray Appoints Michael Murphy as VP, Corporate Controller
Accuray Appoints Michael Murphy as VP, Corporate Controller
Accuray Appoints Michael Murphy as VP, Corporate Controller
ARAY
prnewswire.com21 October 2024

MADISON, Wis. , Oct. 21, 2024 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Michael Murphy, CPA has joined the company as Vice President, Corporate Controller.

Here's Why You Should Retain Accuray Stock in Your Portfolio Now
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
Here's Why You Should Retain Accuray Stock in Your Portfolio Now
ARAY
zacks.com17 October 2024

ARAY's solid product demand and revenue growth raise optimism about the stock.

FAQ

  • What is the primary business of Accuray Incorporated?
  • What is the ticker symbol for Accuray Incorporated?
  • Does Accuray Incorporated pay dividends?
  • What sector is Accuray Incorporated in?
  • What industry is Accuray Incorporated in?
  • What country is Accuray Incorporated based in?
  • When did Accuray Incorporated go public?
  • Is Accuray Incorporated in the S&P 500?
  • Is Accuray Incorporated in the NASDAQ 100?
  • Is Accuray Incorporated in the Dow Jones?
  • When was Accuray Incorporated's last earnings report?
  • When does Accuray Incorporated report earnings?
  • Should I buy Accuray Incorporated stock now?

What is the primary business of Accuray Incorporated?

Accuray Incorporated is a medical technology company that specializes in developing advanced radiation therapy systems for cancer treatment. Their innovative products, like the CyberKnife and TomoTherapy systems, aim to deliver precise and effective radiation while minimizing damage to surrounding healthy tissue, improving patient outcomes in cancer care.

What is the ticker symbol for Accuray Incorporated?

The ticker symbol for Accuray Incorporated is NASDAQ:ARAY

Does Accuray Incorporated pay dividends?

No, Accuray Incorporated does not pay dividends

What sector is Accuray Incorporated in?

Accuray Incorporated is in the Healthcare sector

What industry is Accuray Incorporated in?

Accuray Incorporated is in the Medical Devices industry

What country is Accuray Incorporated based in?

Accuray Incorporated is headquartered in United States

When did Accuray Incorporated go public?

Accuray Incorporated's initial public offering (IPO) was on 08 February 2007

Is Accuray Incorporated in the S&P 500?

No, Accuray Incorporated is not included in the S&P 500 index

Is Accuray Incorporated in the NASDAQ 100?

No, Accuray Incorporated is not included in the NASDAQ 100 index

Is Accuray Incorporated in the Dow Jones?

No, Accuray Incorporated is not included in the Dow Jones index

When was Accuray Incorporated's last earnings report?

Accuray Incorporated's most recent earnings report was on 6 November 2024

When does Accuray Incorporated report earnings?

The next expected earnings date for Accuray Incorporated is 31 January 2025

Should I buy Accuray Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions